Adaptive Biotechnologies
FRANCE LAUNCH COMPASS
OverviewMarket & MRD OpportunityPatient PathwaysCentres & ExpertsLabs & Sample Pathways
Supporting
Downloads
Current view
Indication
All indications
Region
All regions
Facility type
All types
Hub cluster
All clusters
Institution
All institutions
Adaptive Biotechnologies
FRANCE LAUNCH COMPASS · All indications · All regions · All facility types · All hub clusters · All institutions
Overview

France | MRD Intelligence

All indications · All regions · All facility types · All hub clusters · All institutions

Understand the French MRD landscape

Connect MM and CLL patient activity with relevant centres, experts, testing laboratories and referral pathways.

Active treated patients
7,800
MM 4,560 · CLL 3,240
Annual laboratory MRD tests
9,885
8 performing laboratories
Mapped HCPs
35
Haematologists, biologists and pharmacists
Performing laboratories
8
Across the covered centres

Active treated patients by indication

Covered centres · epidemiology records

MRD testing mix by technology

Laboratory test volume · share of filtered tests
EuroFlow NGF (8/10-Color)6,090 · 61.6%
In-House NGS2,880 · 29.1%
EuroFlow NGF + In-House NGS420 · 4.2%
Kit-Based IVD NGS400 · 4.0%
ASO-qPCR95 · 1.0%